Enantiopure 1,4-benzoxazines via 1,2-cyclic sulfamidates. Synthesis of levofloxacin

Organic Letters

Volumn 9, Issue 17, 2007, Pages 3283-3286

  Bower, John F ^a   Szeto, Peter ^b   Gallagher, Timothy ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BENZOXAZINE DERIVATIVE; OFLOXACIN; SULFONAMIDE;

ARTICLE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ANTI-INFECTIVE AGENTS; BENZOXAZINES; OFLOXACIN; STEREOISOMERISM; SULFONAMIDES;

EID: 34548179023     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0712475     Document Type: Article

References (32)

1. For a review on the synthesis and reactivity of cyclic sulfamidates, see: Meléndez, R. E.; Lubell, W. D. Tetrahedron 2003, 59, 2581-2616. Six-ring cyclic sulfamidates, where nitrogen is part of an aziridine ring system, undergo nucleophilic cleavage preferentially at the C-N bond to afford substituted seven-ring cyclic sulfamidates:
2. (a) Duran, F.; Leman, L.; Ghini, A.; Burton, G.; Dauban, P.; Dodd, R. H. Org. Lett. 2002, 4, 2481-2483.
3. (b) Duran, F. J.; Ghini, A. A.; Dauban, P.; Dodd, R. H.; Burton, G. J. Org. Chem. 2005, 70, 8613-8616.
4. (a) Williams, A. J.; Chakthong, S.; Gray, D.; Lawrence, R. M.; Gallagher, T. Org. Lett. 2003, 5, 811-814.
5. (b) Bower, J. F.; Švenda, J.; Williams, A. J.; Charmant, J. P. H.; Lawrence, R. M.; Szeto, P.; Gallagher, T. Org. Lett. 2004, 6, 4727-4730.
6. (c) Bower, J. F.; Szeto, P.; Gallagher, T. Chem. Commun. 2005, 5793-5795.
7. (d) Bower, J. F.; Chakthong, S.; Svenda, J.; Williams, A. J.; Lawrence, R. M.; Szeto, P.; Gallagher, T. Org. Biomol. Chem. 2006, 4, 1868-1877.
8. (e) Bower, J. F.; Szeto, P.; Gallagher, T. Org. Biomol. Chem. 2007, 5, 143-150.
9. (f) Bower, J. F.; Riis-Johannessen, T.; Szeto, P.; Whitehead. A. J.; Gallagher. T. Chem. Commun. 2007, 728-730.
10. For a recent review covering the synthesis and biological importance of 1,4-benzoxazines, see: Ilaš, J.; Anderluh, P. Š.; Dolenc, M. S.; Kikelj, D. Tetrahedron 2005, 61, 7325-7348.
11. For recent approaches to 1,4-benzoxazines and related heterocyclic scaffolds, see: (a) Wolfer, J.; Bekele, T.; Abraham, C J.; Dogo-Isonagie, C.; Lectka, T. Angew. Chem., Int. Ed. 2006, 45, 7398-7400.
12. (b) Xu, D.; Chiaroni, A.; Fleury, M.-B.; Largeron, M. J. Org. Chem. 2006, 71, 6374-6381.
13. (c) Feng, G.; Wu, J.; Dai, W.-M. Tetrahedron 2006, 62, 4635-4642.
14. (d) Shinkevich, E. Y.; Novikov. M. S.; Khlebnikov, A. F. Synthesis 2007, 225-230.
15. Openings of 1,2-cyclic sulfamidates with 2-methoxyphenolate have previously been reported in 47-82% isolated yield: Okuda, M.; Tomioka, K. Tetrahedron Lett. 1994, 35, 4585-4586.
16. For a review on Pd-catalyzed amination. see: (a) Yang, B. H.; Buchwald. S. L. J. Organomet. Chem. 1999, 576, 125-146. For a previous approach to benzoxazines using Ni(0)-mediated intramolecular amination of aryl chlorides, see:
17. (b) Omar-Amrani, R.: Thomas, A.; Brenner, E.; Schneider, R.; Fort, Y. Org. Lett. 2003, 5, 2311-2314. For an example using Pd(0)-mediated intramolecular amination of an aryl chloride, see:
18. (c) Omar-Amrani, R.; Schneider, R.; Fort, Y. Synthesis 2004, 2527-2534.
19. For a previous synthesis of a quinoxalinone via intramolecular Pd-(0)-mediated amination of an aryl iodide, see: Kitagawa. O.; Takahashi,M.; Yoshikawa, M.; Taguchi. T. J. Am. Chem. Soc. 2005, 127, 3676-3677.
20. Other ligands screened included BINAP which gave 9a in 76% yield and Verkade's TTPU ligand (Urgaonkar, S.; Xu, J. H.; Verkade, J. G. J. Org. Chem. 2003, 68, 8416-8423) which gave 9a in 86% yield.
21. An example of a successful Pd-catalyzed cyclization to form a related seven-ring system has been reported.
22. For the preparation of 10d, see: Novak, Z.; Timar, G.; Kotschy, A. Tetrahedron 2003, 59, 7509-7513.
23. For selected previous synthetic studies on 20, see: (a) Hayakawa, I.; Atarashi, S.; Imamura, M.; Yokohama, S.; Higashihashi, N.; Sakano K.; Ohshima, M. US patent, 1986, 5,053,407.
24. (b) Atarashi, S.; Yokohama, S.; Yamazaki, K.; Sakano, K.; Imamura, M.; Hayakawa, I. Chem. Pharm. Bull. 1987, 35, 1896-1902.
25. (c) Sakano, K.; Yokohoma, S.; Hayakawa, I.; Atarashi, S.; Kadoya-, S. Agric Biol. Chem. 1987, 51, 1265-1270.
26. (d) Mitscher, L. A.; Sharma, P. N.; Chu, D. T. W.; Shen, L. L.; Pernet, A. G. J. Med. Chem. 1987, 30, 2283-2286.
27. (e) Atarashi, S.; Tsurumi, H.; Fujiwara, T.; Hayakawa, I. J. Heterocycl. Chem. 1991, 28, 329-331.
28. (f) Kang, S. B.; Ahn, E. J.; Kim, Y.; Kim, Y. H. Tetrahedron Lett. 1996, 37, 9317-9320.
29. (g) Satoh, K.; Inenaga, M.; Kanai, K. Tetrahedron: Asymmetry 1998, 9, 2657-2662.
30. (h) Adrio, J.; Carretero. J. C.; Ruano, J. L. G.; Pallarés, A.; Vicioso, M. Heterocycles 1999, 51, 1563-1572.
31. Tewson has previously reported the synthesis of cyclic sulfamidate 15 in 78% yield from 14: Posakony, J. J.; Grierson, J. R.; Tewson, T. J. J. Org. Chem. 2002, 67, 5164-5169.
32. Pearson, D. E.; Wysong, R. D.; Breder, C. V. J. Org. Chem. 1967, 32, 2358-2360.